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amphiregulin is dispensable for
suppressive functionTo the Editor:
Amphiregulin is 1 of 7 structurally and functionally related
growth factors that bind the epidermal growth factor receptor
(EGFR); it is present in membrane-bound, intracellular and
secreted forms. Interest in a role for amphiregulin in the immune
system has been growing: various cells from both the innate and
adaptive arms of the immune system express the ligand, including
basophils,1 several subsets of humanT cells, andmurineTH2 cells.
2
Populations of tissue-specific murine CD41Foxp31 regulatory T
(Treg) cells in the colon and striatedmuscle are enriched in amphir-
egulin during inflammation; indeed, amphiregulin plays a role in
repair functions of muscle Treg cells.3 Treg cells transferred to
amphiregulin2/2RAG2/2mice show suboptimal ability to prevent
colitis in an adoptive transfer model, a phenotype that is rescued by
amphiregulin supplementation.4 To further understand the potential
role of amphiregulin in Treg-cell function and its role in inflamma-
tion, the abundance and functional significance of amphiregulin
expressed by Treg cells from the peripheral lymphoid tissues of
mice was investigated (see the Methods section and Table E1 in
this article’s Online Repository at www.jacionline.org).
Transcriptomic analysis revealed differential expression of
amphiregulin between conventional T cells (Tcons) and Treg cells
(Fig 1,A andB): amphiregulinmRNAwas greater than 3-foldmore
abundant in Treg cells than in Tcons, confirmed by quantitative
RT-PCR (Fig 1, A, B, and Ci). Heparin-binding epidermal growth
factor-like growth factor (HB-EGF) also showed greater
expression by Treg cells than by Tcons, as did EGFR itself
(Fig 1, A-C); the remaining ligands fell below the limits of
detection (data not shown).
Stimulation of the T-cell receptor (TCR) in human CD31
T cells, CD41 T cells,5 and murine TH2, but not TH1,
6 cells,
induces amphiregulin expression. In human CD41 T cells, TCR
engagement also augments HB-EGF expression.5 To determine 2016 The Authors. Published by Elsevier, Inc. on behalf of the American Academy of
Allergy,Asthma& Immunology. This is an open access article under theCCBY license
(http://creativecommons.org/licenses/by/4.0/).whether a similar response occurs in murine Treg cells and Tcons
(both naive and memory), we examined the kinetics of expression
following TCR stimulation. A spike in amphiregulin expression
was observed in all 3 populations at 3 hours (Fig 1, Di). Highest
expression of amphiregulin mRNA at every time point was
apparent in the Treg cells, followed by the mTcons and then
nTcons. A significant difference between the regulatory and naive
T cells was observed at every time point (Fig 1, Di).
There was no significant difference in HB-EGF expression in
Treg cells over the time course, remaining higher than both Tcon
populations at each point except 72 hours (Fig 1, Dii). In both
subsets of Tcons, EGFR mRNA expression displayed a sustained
increase from the first to the final time point (Fig 1, Diii). To
determine whether the differential expression of the mRNA
encoding amphiregulin and HB-EGF reflected differences in
protein abundance, secreted amphiregulin and HB-EGF were
quantified in culture supernatants. Amphiregulin secreted from
nTcons remained below the assay detection limit of 7.8 pg/mL.
The concentration of amphiregulin in the Treg-cell supernatants
exceeded that of mTcons from 48 hours onward (Fig 1, E).
Concentrations of HB-EGF were below the lower limit of
detection in all supernatant samples (data not shown).
To establish whether the higher amphiregulin expression
observed in Treg cells reflected a role in their suppressive
function, bead-based assays using syngeneic and cross-over
cocultures of Treg cells and Tcons from wild-type (WT)
and amphiregulin knock-out (KO) mice were performed,
following confirmation of their genotype (Fig 2, A). An inhibitory
effect was apparent at all Treg-cell:Tcon ratios, with no difference
between WTand KO cells; in particular, KO:KO cocultures, with
neither an intrinsic nor an extrinsic source of amphiregulin in the
cultures, showed potent suppression (Fig 2, B and C). Moreover,
recombinant amphiregulin added to cultures of T cells in vitro
impacted neither their proliferation nor their apoptosis,
showing no evidence of an inhibitory role (data not shown).
The suppression assays were repeated using WT accessory cells
and soluble anti-CD3 mAb to activate cocultures of WT and
KO Treg cells and Tcons, to establish whether Treg-cell
suppression via antigen-presenting cells requires an intrinsic
source of amphiregulin. Once again, there was no difference in
suppression between any of the coculture permutations.
A regulatory role for amphiregulin is not intuitive, as the ligand
has a number of proinflammatory associations including its
induction of the cytokines IL-1a and IL-1b, which positively
feed back to promote amphiregulin secretion.7 However,
other studies have found a role for the ligand in the function of
various subsets of murine Treg cells.2 Augmentation of human
Treg-cell–mediated suppression of CD41 Tcons in vitro in
response to recombinant amphiregulin was observed by
Zaiss et al.4 In the same study, enhanced activity of murine Treg
cells was also apparent in response to recombinant
amphiregulin, but CD81 T cells were used as the responder
population in these experiments, with no information on the inhib-
itory effect on murine CD41 Tcons. The ligand also enhances
Treg-cell suppression of the antiviral effects of CD81 T cells
in vivo.8 Amphiregulin may therefore augment Treg-cells’ sup-
pressive activity in a CD81 T-cell–specific manner, but whether
amphiregulin itself represents a mechanism of suppression by
Treg cells in certain cellular contexts remains unknown.
Our data demonstrate that despite being more abundantly
expressed by Treg cells than by Tcons, Treg-cell–intrinsic
FIG 1. Treg cells show an amphiregulinhigh phenotype. Peripheral Treg cells and memory (m) and naive (n)
Tcons selected from naive WT mice revealed greater amphiregulin and HB-EGF transcript abundance by
microarray analysis (A: heat map; B: volcano plot) and quantitative RT-PCR assays (C; n >_ 5), both ex vivo
and following polyclonal stimulation (D, n 5 3; E, n >_ 2). AREG, Amphiregulin. Key: Statistical significance
between X 5 Treg cells/nTcons, Y 5 Treg cells/mTcons, and Z 5 nTcons/mTcons (*P < .05, **P < .01,
***P < .001, ****P < .0001).
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because functional redundancy was demonstrated in 2
well-established in vitro assays of suppression, suggesting that
amphiregulin cannot be considered a core regulatory mechanism
of these cells. Rather, we speculate that amphiregulin is involved
in the tissue-reparative effects of Treg cells, in a manner that is
independent of regulatory function. This viewpoint is supported
by recently published work that complements our study2,9 and
extends our current insight into the complex, multifaceted roles
of amphiregulin in health and disease.
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rhinovirus severe bronchiolitis are
associated with distinct nasopha-
ryngeal microbiotaTo the Editor:
Bronchiolitis is the leading cause of infant hospitalization in the
United States,1 and cohort studies suggest that up to 50% of these
hospitalized infants will develop childhood asthma.1 The 2 mostcommon viral etiologies of severe bronchiolitis (ie, bronchiolitis
requiring hospitalization) are respiratory syncytial virus (RSV)
and rhinovirus (RV).1 Although these 2 viruses have been the
focus of most previous cohorts examining the association
between bronchiolitis and asthma, RSV and RV infect
infants through a respiratory tract colonized with bacteria.2,3
Cross-sectional and prospective data suggest that the respiratory
microbiota may also play a role in the development of childhood
asthma.2 To date, no studies have examined the relationship
between the respiratory viruses, RSVand RV, and the respiratory
microbiota of infants hospitalized with bronchiolitis. This
knowledge gap has hindered the development of new conceptual
models regarding the bronchiolitis to asthma pathway in this very
high-risk population.
The 35thMulticenter Airway Research Collaboration (MARC-
35) is a 17-center, prospective cohort study of 1016 infants (age
<1 year) hospitalized with bronchiolitis who we are following for
the development of recurrent wheezing and eventual asthma. For
3 consecutive years (2011-2014) from November to April,
researchers collected clinical data and used a standardized
protocol to collect nasopharyngeal aspirates (NPAs) within
24 hours of hospitalization.4 We tested these 1016 NPAs for 17
viruses using real- time PCR, as described previously,4 and
